Table 1.

The effect of PAF on hemodynamic behavior of SS RBC in the mesocecum vasculature

Infusion No. PRU (mm Hg/mL/min/g) ΔPRU (%) Tpf (s)
Ringer RBC
1. AA RBC  4  4.0 ± 0.1  4.6 ± 0.1 15.0 ± 2.3  31.5 ± 1.9  
2. PAF/AA RBC  5.1 ± 0.7  6.0 ± 0.9  17.6 ± 1.7 37.0 ± 6.3  
3. SS RBC  4  4.2 ± 1.0 5.2 ± 1.3  25.2 ± 3.0* 49.9 ± 2.3 
4. PAF/SS RBC  4  6.4 ± 1.9  9.0 ± 2.5 40.5 ± 6.7 90.8 ± 13.91-153 
Infusion No. PRU (mm Hg/mL/min/g) ΔPRU (%) Tpf (s)
Ringer RBC
1. AA RBC  4  4.0 ± 0.1  4.6 ± 0.1 15.0 ± 2.3  31.5 ± 1.9  
2. PAF/AA RBC  5.1 ± 0.7  6.0 ± 0.9  17.6 ± 1.7 37.0 ± 6.3  
3. SS RBC  4  4.2 ± 1.0 5.2 ± 1.3  25.2 ± 3.0* 49.9 ± 2.3 
4. PAF/SS RBC  4  6.4 ± 1.9  9.0 ± 2.5 40.5 ± 6.7 90.8 ± 13.91-153 

Values are mean ± SD. In experiments using PAF, the vasculature was first pretreated with PAF (200 pg/mL) followed by a bolus infusion of SS RBC (Hct 30%, 0.2 mL).

Abbreviations: ΔPRU, PRU RBC/PRU Ringer; Tpf, pressure-flow recovery time to the baseline level.

*

P < .002 and

P < .0001, compared with respective values for AA RBC.

P < .024 and

F1-153

P < .013, compared with respective values for SS RBC.

or Create an Account

Close Modal
Close Modal